K. Ohe et al. / Tetrahedron: Asymmetry 13 (2002) 2155–2160
2159
(v/v=3:1, 40 mL) at 10°C. The mixture was stirred at
the same temperature for 16 h. After removing the
solvent under vacuum, water (20 mL) was added and
then the product was extracted with CHCl3 (3×20 mL).
The organic layer was dried over MgSO4. The solvent
was removed under vacuum and the orange residue was
subjected to column chromatography on SiO2 with
petroleum ether–EtOAc (v/v=3:2) as an eluent to give
the title compound 6 (0.60 g, 1.35 mmol, 75%) as a
white solid: mp 76.4–77.5°C; [h]2D3=+73.8 (c 0.5,
stirred at room temperature for 15 min under Ar. The
solvent was removed under vacuum, and the white
residue was subjected to column chromatography on
Al2O3 with CHCl3 as an eluent to give the title com-
pound 3% (0.069 g, 0.085 mmol, 47%) as a white solid:
mp 90.3–92.0°C; [h]2D3=+40.4 (c 0.25, CHCl3); 1H
NMR (400 MHz, CDCl3) l 0.98 (s, 3H), 1.07 (s, 3H),
1.37 (s, 3H), 1.44 (s, 3H), 1.53 (s, 3H), 1.54 (s, 3H), 3.25
(s, 1H), 3.29–3.34 (m, 1H), 3.39 (dd, J=4.9, 10.5 Hz,
1H), 3.49 (dd, J=3.2, 9.0 Hz, 1H), 3.63 (t, J=10.5 Hz,
1H), 3.72 (t, J=10.5 Hz, 1H), 3.82–3.89 (m, 2H),
4.06–4.10 (m, 2H), 4.29 (m, 1H), 4.46 (m, 1H), 4.84 (d,
J=6.8 Hz, 1H), 5.33 (d, J=2.9 Hz, 1H), 7.13–7.71 (m,
20H); 13C NMR (75 MHz, CDCl3) l 19.2, 19.2, 26.1,
26.8, 28.5, 29.2, 59.4, 60.0, 62.0, 62.3, 65.5, 70.0 (d,
J=4.4 Hz), 73.7, 74.0, 76.3, 77.2, 92.2, 93.4, 94.0 (d,
J=24.9 Hz), 99.7, 111.6, 127.8–135.6 (22 carbons),
143.7, 143.9; 31P NMR (161.9 Hz, CDCl3) l −18.3,
117.9 ppm. HRMS (FAB) calcd for C45H53O10P2 (M+
H+): 815.3114. Found: 815.3122.
1
CHCl3); H NMR (400 MHz, CDCl3) l 1.45 (s, 6H),
1.46 (s, 3H), 1.51 (s, 3H), 1.52 (s, 3H), 1.55 (s, 3H), 3.40
(m, 1H), 3.48 (dd, J=2.9, 9.3 Hz, 1H), 3.54 (dd, J=2.9,
9.3 Hz, 1H), 3.63–3.72 (m, 2H), 3.81–3.91 (m, 3H), 3.93
(t, J=9.3 Hz, 1H), 4.00–4.02 (m, 2H), 4.18 (t, J=9.8
Hz, 1H), 5.24 (d, J=2.9 Hz, 1H), 5.44 (d, J=2.9 Hz,
1H); 13C NMR (67.5 MHz, CDCl3) l 18.9, 19.1, 26.2,
26.8, 29.0, 50.7, 52.8, 61.1, 62.1, 62.3, 65.9, 70.2, 73.4,
73.8, 76.5, 91.0, 94.1, 99.7, 100.0, 111.7 ppm. HRMS
(FAB) calcd for C21H33O10 (M+H+): 445.2074. Found:
445.2061.
3.6. [Rh(a-D-glucopyranosyl-(1,1)-2-(diphenylphosphino)-
3.4. 2,3:4,6-Di-O-isopropylidene-a-
(1,1)-4,6-O-isopropylidene-2-(diphenylphosphino)-2-
deoxy-a- -altropyranoside, 7
D-glucopyranosyl-
2-deoxy-3-O-(diphenylphosphino)-a-
D
-altropyranoside)-
(1,5-cyclooctadiene)]+BF4 , 8
−
D
[Rh(acac)(cod)] (13.3 mg, 0.043 mmol) and 3% (36 mg,
0.045 mmol) were dissolved in degassed dry THF (1.0
mL) under Ar and the mixture was stirred for 15 min.
Aqueous 40% HBF4 solution (0.2 mL) was added to the
mixture and the reaction mixture was stirred at room
temperature for 1 h. Degassed dry Et2O (30 mL) was
added, and then the yellow solid was precipitated. The
supernatant solution was removed by syringe, and the
title complex 8 (21.8 mg, 0.022 mmol, 51%) was
obtained as yellow crystals: mp 230.0–231.5°C; 31P
To a solution of 6 (0.20 g, 0.45 mmol) in degassed THF
(10 mL) was added dropwise a solution of 0.5 M
potassium diphenylphosphide (1.35 mL, 0.68 mmol) in
THF at −78°C. The mixture was stirred at room tem-
perature for 2 h under Ar. To the reaction mixture was
added NH4Cl (1.0 g) and the mixture was stirred for 0.5
h. After removal of excess NH4Cl insoluble in THF, the
solvent was removed under vacuum, and the residue
was subjected to column chromatography on SiO2 with
CHCl3–AcOEt (v/v=1:3) as an eluent to give the title
compound 7 (0.17 g, 0.27 mmol, 60%) as a white solid:
mp 104.3–106.0°C; [h]2D3=+78.9 (c 0.5, CHCl3); 1H
NMR (270 MHz, CDCl3) l 1.42 (s, 3H), 1.46 (s, 3H),
1.48 (s, 3H), 1.48 (s, 3H), 1.52 (s, 6H), 3.22–3.34 (m,
2H), 3.42–3.53 (m, 2H), 3.66 (t, J=10.7 Hz, 1H),
3.82–3.91 (m, 4H), 4.07 (t, J=9.3 Hz, 1H), 4.17 (m,
2H), 4.87 (d, J=5.5 Hz, 1H), 5.32 (d, J=3.3 Hz, 1H),
7.37–7.87 (m, 10H); 13C NMR (67.5 MHz, CDCl3) l
19.1, 19.2, 26.2, 26.7, 29.0, 29.1, 44.6 (d, J=16.1 Hz),
59.6, 61.8, 62.4, 65.9, 66.9 (d, J=16.1 Hz), 69.6 (d,
J=7.3 Hz), 73.4, 73.7, 75.8, 92.2, 94.0 (d, J=21.8 Hz),
99.6, 99.9, 111.8, 128.8, 128.9, 129.0, 129.0, 129.6,
130.0, 130.6, 130.7, 132.8 (d, J=21.8 Hz), 133.5 (d,
J=21.8 Hz), 134.9 (d, J=13.0 Hz), 135.3 (d, J=14.5
Hz); 31P NMR (161.9 Hz, CDCl3) l −20.5 ppm. HRMS
(FAB) calcd for C33H44O10P (M+H+): 631.2672. Found:
631.2692.
NMR (161.9 Hz, CD3OD) l 19.2 (dd, JP–P=49, JP–Rh
=
147 Hz), 120.5 (dd, JP–P=49, JP–Rh=165 Hz) ppm.
LRMS (FAB) m/z 905 (M+−BF4). HRMS (FAB) calcd
for C44H52O10P2Rh (M+−BF4): 905.2091. Found:
905.2096.
3.7. A typical procedure for the hydrogenation of dehy-
droamino acids in an aqueous/organic medium (H2O–
EtOAc) using the complex 8
The Rh complex 8 (2.0 mg, 0.20×10−2 mmol) was
dissolved in degassed H2O (1.0 mL), and the solution
was injected into a stainless steel autoclave with glass
container by a syringe under Ar. To this solution was
added a solution of methyl a-acetamide (Z)-cinnamate
(21.8 mg, 0.10 mmol) in degassed EtOAc (1.0 mL) by a
syringe under Ar, and the mixture was stirred vigor-
ously under H2 pressure (50 atm). When the reaction
was complete (as confirmed by GLC, TLC, or 1H
NMR) the organic layer was separated by decantation,
and the removal of solvent under vacuum gave the
crude product as a pale yellow oil. Purification of the
crude product by column chromatography on SiO2 with
petroleum ether–EtOAc (v/v=1:10) as eluent gave N-
acetylphenylalanine methyl ester. The enantiomeric
excess was determined by HPLC using a Daicel Chiral-
cel OJ column [1.0 mL/min, 10% 2-PrOH/hexane; (R)
3.5. 2,3:4,6-Di-O-isopropylidene-a-
(1,1)-4,6-O-isopropylidene-2-(diphenylphosphino)-2-
deoxy-3-O-(diphenylphosphino)-a- -altropyranoside, 3%
D-glucopyranosyl-
D
To a solution of 7 (0.11 g, 0.18 mmol), 4-(N,N-
dimethylamino)pyridine (DMAP) (2.0 mg, 0.24 mmol),
and triethylamine (1.0 mL, 7.1 mmol) in degassed THF
(1.0 mL) was slowly added chlorodiphenylphosphine
(0.03 mL, 0.20 mmol) and the reaction mixture was